John Overdeck’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681K Buy
+63,248
New +$800K ﹤0.01% 3913
2025
Q3
Sell
-27,641
Closed -$416K 3762
2025
Q2
$416K Sell
27,641
-19,621
-42% -$287K ﹤0.01% 2666
2025
Q1
$711K Sell
47,262
-11,254
-19% -$166K ﹤0.01% 2354
2024
Q4
$843K Sell
58,516
-12,471
-18% -$223K ﹤0.01% 2282
2024
Q3
$1.39M Sell
70,987
-20,161
-22% -$365K ﹤0.01% 1912
2024
Q2
$1.56M Buy
91,148
+55,318
+154% +$1.02M ﹤0.01% 1718
2024
Q1
$602K Buy
35,830
+17,830
+99% +$271K ﹤0.01% 2248
2023
Q4
$326K Sell
18,000
-8,966
-33% -$163K ﹤0.01% 2662
2023
Q3
$457K Buy
26,966
+13,266
+97% +$190K ﹤0.01% 2316
2023
Q2
$164K Sell
13,700
-5,100
-27% -$69.6K ﹤0.01% 2681
2023
Q1
$245K Buy
+18,800
New +$308K ﹤0.01% 2500

Other funds holding HCM

John Overdeck's HCM Position: Q2 2026 in Review

John Overdeck opened a new position in HUTCHMED (HCM) in Q2 2026: 63,248 shares worth $681K. The stake represents ﹤0.01% of the portfolio and ranks #3913 among its holdings. This is a return to the name: John Overdeck previously reported a position in HCM as recently as Q2 2025.

John Overdeck first reported a position in HCM in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.56M in Q2 2024. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

  • John Overdeck held 63,248 shares of HUTCHMED worth $681K as of Q2 2026.
  • HUTCHMED was a new John Overdeck position in Q2 2026.
  • HUTCHMED made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3913 holding.
  • John Overdeck first reported a position in HUTCHMED in Q1 2023 and has held it in 11 quarters since.
  • John Overdeck's HUTCHMED position peaked at $1.56M in Q2 2024.
  • 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.